Showing results (321-330 of 360) with videos related to
Sort By:
Pageof 36
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
Bimodal modulation of the botulinum neurotoxin protein-conducting channelAudrey Fischer, Yuya Nakai, Lisa M Eubanks, et al.ACS Medicinal Chemistry Letters|August 20, 2021
Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A ProteaseLewis D Turner, Alexander L Nielsen, Lucy Lin, et al.Bioorganic & Medicinal Chemistry Letters|February 4, 2012
The use of small molecule probes to study spatially separated stimulus-induced signaling pathwaysVladimir V Kravchenko, Christian Gloeckner, G Neil Stowe, et al.Biological Psychiatry|October 27, 2012
A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsMichelle L Miller, Amira Y Moreno, Shawn M Aarde, et al.Journal of the American Chemical Society|March 2, 2006
Antibody interference with N-acyl homoserine lactone-mediated bacterial quorum sensingGunnar F Kaufmann, Rafaella Sartorio, Sang-Hyeup Lee, et al.Vaccine|April 30, 2013
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogsGary R Matyas, Alexander V Mayorov, Kenner C Rice, et al.Biochemistry|August 2, 2006
Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligandYoungsoo Kim, Antonietta M Lillo, Sebastian C J Steiniger, et al.Proceedings of the National Academy of Sciences of the United States of America|December 30, 2004
Revisiting quorum sensing: Discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactonesGunnar F Kaufmann, Rafaella Sartorio, Sang-Hyeup Lee, et al.Journal of Medicinal Chemistry|June 23, 2011
A vaccine strategy that induces protective immunity against heroinG Neil Stowe, Leandro F Vendruscolo, Scott Edwards, et al.Clinical & Experimental Metastasis|March 13, 2010
Targeting activated integrin alphavbeta3 with patient-derived antibodies impacts late-stage multiorgan metastasisKarin Staflin, Joseph S Krueger, Janna Hachmann, et al.Pageof 36